Overview
Tab Title Description
Study type
InterventionalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Jacksonville, Florida: 22-001562
Sponsor Protocol Number: MC220502
About this study
The purpose of this study is to employ mixed methods approach to develop a prostate cancer survivorship care plan (CaP-SCP) tailored to US-born Black men (USbBM), Caribbean-born BM (CBBM) and African-born BM (ABBM) using clinicians’ key informant interviews and survey of CaP Black survivors and to develop a prototype of the digitalized CaP-SCP that integrates quantitative clinical, patient reported health-related quality of life (HRQOL) and population level data to assess the sensitivity and preliminary impact of the digitalized CaP-SCP on Health Related Quality of Life (HRQOL) using community engagement research and behavioral precision medicine.
Augmented reality (AR) immersive technology in healthcare delivers unprecedented, intuitive, realistic visualization and interaction experience for patients in a synthetic and integrated fashion. AR can help patients to manage emotions, pain, combat anxiety or fears, and make better decisions. Combined with Artificial Intelligence (AI), with benefits of accurate machine-learning models, we propose to develop an integrated AI and AR technology Prostate Cancer (CaP) Survivorship Care Plan.
The digitalized CaP-SCP development will be led by the iCCaRE consortium’s Digital Health & Human Services core. They will develop a mobile app that integrates SDOH navigation, standard CaP psycho-oncology support and emotional support. The app’s content will be delivered through AI predictive analytic and recommender system and will be based on the previously conducted interviews and focus groups.
The digitalized CaP-SRP when used by a patient, will present the following features:
• A series of short survey questions, which is used by the AI model to predict or recommend a specific intervention(s), educative material(s), or AR interactions with personal CaP survival stories;
• SDOH navigation that will appropriately connect them with relevant support services and resources in their communities;
• An emotional support intervention that can establish an empathic rapport with a CaP survivor’s sharing of his story. This will be programmed based on one of the iCCaRe Consortium’s consumer advocates;
• The psycho-oncology support will be programmed to provide psychoeducation about the PPCD experience, reify and concretize the PPCD experience, and foster hope;
• Patients can choose to ignore the personalized recommendations and select from a drop-down menu list of contents.
The app is expected to be downloaded to their mobile smartphone for introduction in the clinical setting and more in-depth use at home. The survivorship care plan can be taken with participants to follow-up appointments for reminders and updates to treatments. We anticipate participants acclimating to the app for approximately 30 minutes in the clinic